Hiding from allogeneic NK cells and macrophages by a synthetic receptor
Authors:
- 2 November 2023
- journal article
- editorial
- Published by Elsevier in Cell Stem Cell
- Vol. 30 (11) , 1393-1394
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development
- Kyoto University
This publication has 9 references indexed in Scilit:
- Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicityCell Stem Cell, 2023
- Protection of cell therapeutics from antibody-mediated killing by CD64 overexpressionNature Biotechnology, 2023
- Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical applicationMolecular Therapy - Methods & Clinical Development, 2022
- Immunogenicity of CAR-T Cell Therapeutics: Evidence, Mechanism and MitigationFrontiers in Immunology, 2022
- Generation of hypoimmunogenic human pluripotent stem cellsProceedings of the National Academy of Sciences, 2019
- Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune CompatibilityCell Stem Cell, 2019
- Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipientsNature Biotechnology, 2019
- HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cellsNature Biotechnology, 2017
- Retroviral vector silencing during iPS cell induction: An epigenetic beacon that signals distinct pluripotent statesJournal of Cellular Biochemistry, 2008